P588 Ustekinumab for the treatment of Crohn's disease patients with TNF antagonist induced psoriasis. Real life experience from a tertiary referral center through week 54 | Zendy

AI Assistant Blog Pricing

P588 Ustekinumab for the treatment of Crohn's disease patients with TNF antagonist induced psoriasis. Real life experience from a tertiary referral center through week 54

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.